According to the company, effective January 1, 2025, cyclosporine ophthalmic solution 0.1% (Vevye) will be included on key ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

Cold water has been tossed on the idea that CVS Health would break up the company and sell off health or pharmacy benefits from assets that provide medical care. In his first earnings call following a ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

That helped CVS’ health services segment (which also includes the Caremark pharmacy benefit manager) grow its sales of ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various ...

The pharmacy benefit managers, which were named in two of the complaints—CVS Caremark, Express Scripts, MedImpact, and ...

Steve Nelson, a former chief executive officer of UnitedHealthcare, has been named the president of Hartford-based Aetna, ...

CVS did not break out separate enrollment figures for fully insured group health plans when it posted its earnings.

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...